Registry of Pulmonary Embolism Outcomes in Poland
Official title: Polish Multicenter Pulmonary Embolism Response Teams Outcomes Registry
Run by Poznan University of Medical Sciences · NCT04879069 · Data updated 2026-11-12
This study is collecting information about how patients with acute pulmonary embolism are treated and what happens to them in Poland to improve care for everyone with this condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Poznan University of Medical Sciences Academic / other |
| Locations | 1 site (Poznan, GreaterPoland) |
| Status | Recruiting |
| Started | June 1, 2018 |
| Main results expected | June 2023 |
| Study ends | December 2030 |
| Registry record updated | May 10, 2021 |
| Trial ID | NCT04879069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with confirmed pulmonary embolism experiencing symptoms for 14 days or less, particularly those with high-risk features or right ventricle dysfunction.
✕Probably not a fit
Patients who refuse to sign the informed consent form will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to document the current practices and outcomes for patients with acute pulmonary embolism (PE) treated by Pulmonary Embolism Response Teams (PERTs) across Poland. It collects data on patient clinical status, co-morbidities, treatment modalities, and outcomes, including complications such as respiratory failure and major bleeding. The study is observational and does not influence the standard diagnosis and treatment of patients. The data is managed by the Poznan University of Medical Sciences, ensuring a comprehensive overview of PE management in the region.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of PE management and improve patient outcomes through better-informed treatment strategies.
How similar studies have gone: While the PERT concept has been implemented in various settings, this specific registry approach is novel in Poland and aims to gather localized data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. PE confirmed by computed tomography pulmonary angiography. 2. PE symptoms duration ≤ 14 days. 3. High-risk PE with hemodynamic instability (one of): * cardiac arrest * obstructive shock * persistent hypotension. 4. Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level. Exclusion Criteria: 1\. Refusal to sign the informed consent form.
Where it's running
-
Poznan University of Medical Sciences
Poznan, GreaterPoland, Poland Recruiting
Study contacts
- Principal investigator: Aleksander Araszkiewicz, Prof. — Poznan University of Medical Sciences
- Study coordinator: Aleksander Araszkiewicz
- Email: aaraszkiewicz@ump.edu.pl
- Phone: 8549146
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Repeated exams to classify early pulmonary embolism
This project will test whether doing repeated blood tests, ECGs, and bedside heart ultrasounds during the first 48 hours after pulmonary embolism helps predict who will get worse in adults treated at Sahlgrenska University Hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.